Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences has provided additional details regarding the stakeholders involved in its Reorganization Framework Agreement, including ownership percentages of Med-Fine Venture Fund I, L.P., Changzhou Jifeng, and Wuhan Jifeng. The company has clarified the ownership structure of these entities, revealing significant stakes held by individual investors and other companies. This supplemental announcement follows a previous disclosure on August 30, 2024, and is intended to inform shareholders and potential investors.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.